divendres, 23 de maig del 2014

Op-Ed: How to survive the Zimmer/Biomet merger




Despite leadership's promises to "keep everybody" after the Zimmer/Biomet mega-merger, executive search & consulting expert Drue DeAngelis is certain that deep cuts are on the way.





Op-Ed: How to survive the Zimmer/Biomet merger

By Drue DeAngelis




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vTpcIt

Cap comentari:

Publica un comentari a l'entrada